38 / 56
38
educational Seminars
w
Registration fee for Educational Seminars and Meet the Experts, per session: EUR 50.
Only valid in combination with the congress registration fee.
E
Friday, 21 April 2017
ES-04
Educational Seminar
17:45–18:45
East Meetingroom 13
Treatment of ADHD and substance abuse
Chair: J. A. Ramos-Quiroga, Spain
Description
Substance use disorders (SUDs) constitute a major
health problem and are associated with an extensive
psychiatric comorbidity in youth. SUDs have estimated
prevalence rates of 3.4% for alcohol dependence and
0.3–1.8% for cannabis dependence in the general
population. ADHD is a highly comorbid disorder in
patients with substance use disorders (SUD). A meta-
analytic review of the literature showed a prevalence of
ADHD in adolescent and adult SUD patients of 23%. In
an international multicenter study, the IASP study, the
overall prevalence of adult ADHD in treatment seeking
SUD patients was still as high as 14%. It is essential the
correct assessment of psychiatric comorbidity in ADHD
because the patient's comorbidity profile will influence
treatment planning. The seminar provides an overview
of the treatment of ADHD in patients with SUDs. The
multiple challenges that commonly appear during the
treatment of this comorbidity are discussed.
ME-01
Meet-the-Expert-Session
17:45–18:45
East Meetingroom 14
A missing window: The assessment and treatment of
ADHD in the transition of adolescence to adulthood
Chair: S. Dalsgaard, Denmark
Description
Adolescence is a period of change - for everyone. The
transition from being an adolescent to becoming an
independent adult is often especially difficult for those
with ADHD. Some adolescents with ADHD can be more
irritable and oppositional than their peers and this often
has consequences for the treatment-plan. Parents often
ask clinicians: “Is this just normal adolescent behaviour
or is the ADHD changing?” Adolescents with ADHD and
their parents often experience more conflicts in their
relationship and they both need counselling about that.
In my clinical work with this age group I focus very much
on getting the adolescent on board in the treatment
plan and try to create a window of opportunity for
them to express their opinions and I try to guide the
parents to listen to those opinions. The risk of comorbid
substance abuse increases during adolescence and this
has implications for both assessment and treatment. In
this session I will talk about my own clinical experiences
with the problems during this period of transition and
how I try to solve them.